SAM #SPE2DP26R0002

Solicitation for Southern Hemisphere Influenza Vaccine (2027-2028 Flu Season)

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is seeking suppliers for the Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain - Contracting Officer: Melissa Rios Thomas - Product Requested: - Influenza Virus Vaccine, Southern Hemisphere 2027 formula - For individuals aged 6 months and older - 0.5 ml dose, pre-filled in commercially available syringes - Packaged 10 syringes per package - Annual estimated quantity: 3,000 packages (30,000 doses) - Preservative-free, single-dose, suitable for intramuscular administration - Must be FDA-approved and ACIP recommended - Must meet cold chain management requirements - National Stock Numbers to be established at award - Delivery & Contract Details: - Delivery to DLA Distribution Susquehanna, PA - 100% of quantities required by end of March 2027 (accelerated delivery allowed) - Indefinite delivery, indefinite quantity contract - Guaranteed minimum: 2,250 packages (75% of estimate) - Maximum: 4,500 packages (150% of estimate) - Unique Requirements: - Vaccine formula to be determined by FDA advisory committee - Must be preservative-free and suitable for ages 6 months and older - Strict cold chain management required - No specific OEMs or vendors are named; open to all FDA-approved manufacturers

Description

The Defense Logistics Agency Troop Support is soliciting for the supply of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. Approximately 30,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be a pre-measured 0.5 ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The vaccine shall be U.S. Food & Drug Administration (FDA)-approved and U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. The formula for the 2027-2028 season vaccine shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award. An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. (Quantities may increase or decrease pending receipt of final Service requirements.) The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate. All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 100% of the requirements by March 12, 2027. This delivery schedule is the preferred delivery schedule. Other delivery schedules will be considered. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (rosbert.jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is September 28, 2026, closing on Ocrtober 14, 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date. Additional Links:PresolicitationSources Sought

View original listing